CI
BMY icon

Cordant Inc’s Bristol-Myers Squibb BMY Stock Holding History

Cordant Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122 Buy
+2
New +$115 ﹤0.01% 325
2022
Q2 		– Sell
-251
Closed -$18K – 217
2022
Q1 		$18K Buy
+251
New +$16.9K 0.01% 83
2021
Q4 		– Sell
-24
Closed -$1K – 112
2021
Q3 		$1K Sell
24
-151
-86% -$9.94K ﹤0.01% 219
2021
Q2 		$12K Buy
+175
New +$11.4K 0.01% 75
2020
Q1 		– Sell
-218
Closed -$14K – 80
2019
Q4 		$14K Buy
+218
New +$12.5K 0.01% 68

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Cordant Inc's BMY Position: Q2 2026 in Review

Cordant Inc opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 2 shares worth $122. The stake represents ﹤0.01% of the portfolio and ranks #325 among its holdings. This is a return to the name: Cordant Inc previously reported a position in BMY as recently as Q1 2022.

Cordant Inc first reported a position in BMY in Q4 2019 and has held it in 5 quarters since. The position peaked at $18K in Q1 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cordant Inc held 2 shares of Bristol-Myers Squibb worth $122 as of Q2 2026.
  • Bristol-Myers Squibb was a new Cordant Inc position in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #325 holding.
  • Cordant Inc first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 5 quarters since.
  • Cordant Inc's Bristol-Myers Squibb position peaked at $18K in Q1 2022.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.